| A systematic review of the worldwide prevalence and incidence of Parkinson’s disease W Muangpaisan, A Mathews, H Hori, D Seidel Journal of the Medical Association of Thailand 94 (6), 749, 2011 | 251 | 2011 |
| Sensitive detection of mono-and polyclonal ESR1 mutations in primary tumors, metastatic lesions, and cell-free DNA of breast cancer patients P Wang, A Bahreini, R Gyanchandani, PC Lucas, RJ Hartmaier, ... Clinical cancer research 22 (5), 1130-1137, 2016 | 214 | 2016 |
| Prevalence of triple-negative breast cancer in India: systematic review and meta-analysis GS Sandhu, S Erqou, H Patterson, A Mathew Journal of global oncology 2 (6), 412-421, 2016 | 114 | 2016 |
| Global survey of clinical oncology workforce A Mathew Journal of global oncology 4, 1-12, 2018 | 109 | 2018 |
| Combined Blockade of Activating ERBB2 Mutations and ER Results in Synthetic Lethality of ER+/HER2 Mutant Breast Cancer S Croessmann, L Formisano, LN Kinch, PI Gonzalez-Ericsson, ... Clinical Cancer Research 25 (1), 277-289, 2019 | 105 | 2019 |
| Recurrent hyperactive ESR1 fusion proteins in endocrine therapy-resistant breast cancer RJ Hartmaier, SE Trabucco, N Priedigkeit, JH Chung, CA Parachoniak, ... Annals of oncology 29 (4), 872-880, 2018 | 101 | 2018 |
| Distinct pattern of metastases in patients with invasive lobular carcinoma of the breast A Mathew, PS Rajagopal, V Villgran, GS Sandhu, RC Jankowitz, M Jacob, ... Geburtshilfe und Frauenheilkunde 77 (06), 660-666, 2017 | 98 | 2017 |
| Transcriptome characterization of matched primary breast and brain metastatic tumors to detect novel actionable targets D Varešlija, N Priedigkeit, A Fagan, S Purcell, N Cosgrove, PJ O’Halloran, ... JNCI: Journal of the National Cancer Institute 111 (4), 388-398, 2019 | 95 | 2019 |
| Bisphosphonates in breast cancer A Mathew, A Brufsky International journal of cancer 137 (4), 753-764, 2015 | 57 | 2015 |
| Financial toxicity in cancer care in India: a systematic review JM Boby, S Rajappa, A Mathew The Lancet Oncology 22 (12), e541-e549, 2021 | 48 | 2021 |
| Rising thyroid cancer incidence in Southern India: an epidemic of overdiagnosis? IE Mathew, A Mathew Journal of the Endocrine Society 1 (5), 480-487, 2017 | 46 | 2017 |
| Trends in colorectal cancer incidence in India. V Mathew Thomas, B Baby, K Wang, F Lei, Q Chen, B Huang, A Mathew Journal of Clinical Oncology 38 (15_suppl), e16084-e16084, 2020 | 32 | 2020 |
| A case of fatal Guillain–Barre syndrome from anti-PD1 monoclonal antibody use A Jacob, DC Unnikrishnan, A Mathew, B Thyagarajan, S Patel Journal of cancer research and clinical oncology 142, 1869-1870, 2016 | 31 | 2016 |
| Long‐term treatment with intravenous bisphosphonates in metastatic breast cancer: A retrospective study AM Brufsky, SM Sereika, A Mathew, O Tomifumi, V Singh, M Rosenzweig The breast journal 19 (5), 504-511, 2013 | 28 | 2013 |
| Trends in thyroid cancer incidence in India. J Sekkath Veedu, K Wang, F Lei, Q Chen, B Huang, A Mathew Journal of Clinical Oncology 36 (15_suppl), e18095-e18095, 2018 | 25 | 2018 |
| Adjuvant endocrine therapy for premenopausal women with hormone-responsive breast cancer A Mathew, NE Davidson The Breast 24, S120-S125, 2015 | 25 | 2015 |
| Colorectal cancer incidence in younger adults in India A Mathew, B Baby, K Wang, B Sirohi, F Lei, Q Chen, B Huang Gut 69 (10), 1899-1900, 2020 | 24 | 2020 |
| Thyroid cancer incidence in India between 2006 and 2014 and impact of overdiagnosis C Panato, S Vaccarella, L Dal Maso, P Basu, S Franceschi, D Serraino, ... The Journal of Clinical Endocrinology & Metabolism 105 (8), 2507-2514, 2020 | 23 | 2020 |
| Comprehensive genomic profiling in routine clinical practice leads to a low rate of benefit from genotype-directed therapy T Hilal, M Nakazawa, J Hodskins, JL Villano, A Mathew, G Goel, ... BMC cancer 17, 1-8, 2017 | 22 | 2017 |
| Bisphosphonates, bone, and breast cancer recurrence A Brufsky, A Mathew The Lancet 386 (10001), 1319-1320, 2015 | 22 | 2015 |
Adam BrufskyProfessor of Medicine, University of PittsburghVerified email at upmc.edu
